HomeIndustriesBiotechnology

Biotechnology

Eureka Therapeutics Advances ARYA-3 Clinical Trial to Phase II for Treatment of Liver Cancer Using GPC3-Targeting ARTEMIS® T-cell Therapy

Eureka Therapeutics, Inc., a clinical-stage biotechnology company developing novel T-cell therapies to treat cancer, announced the advancement of its ARYA-3 clinical trial to Phase...

Kindeva Drug Delivery Welcomes Jennifer Riter, New Vice President of Analytical Services

Kindeva Drug Delivery (Kindeva), a global leader in drug-device combination products, today welcomes Jennifer Riter as Vice President of Analytical Services to head up the recently announced analytical...

X-Therma’s $22.4M Series B Sets Stage to Transform Regenerative Medicine and Organ Transplantation

Oversubscribed round propels company towards clinical trials and global market expansion, promising to extend organ preservation times and revolutionize healthcare. X-Therma Inc., a biotechnology company...

Poseida Therapeutics Announces FDA Orphan Drug Designation Granted to P-BCMA-ALLO1 for the Treatment of Multiple Myeloma

Data Describing Activity of P-BCMA-ALLO1 in BCMA-Experienced Patients to be Presented at Upcoming AACR Meeting Poseida Therapeutics, Inc., a clinical-stage cell and gene therapy company...

Biosero Appoints Daniel Schumann as Chief Operations Officer

Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, announced the appointment of Daniel Schumann to the position of chief operations officer....
0FansLike
0FollowersFollow
spot_img

Hot Topics